Lv5
828 积分 2024-05-09 加入
Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC
10天前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
3个月前
已完结
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
4个月前
已完结
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials
5个月前
已完结
Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small-cell lung cancer
8个月前
已完结
Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression
9个月前
已完结
皖公网安备34019202002308
